MCI Onehealth and Oro Health Collaborate to Launch New Teledermatology Platform

AI-driven MCI Dermatology Connect speeds access to specialists

MCI Onehealth Technologies , a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and Oro Health, a provider of Asynchronous Telemedicine combined with artificial intelligence-based solutions for medical specialists, announced the launch of collaboratively developed MCI Dermatology Connect. The launch of MCI Dermatology Connect will help meet the need of Ontarians currently waiting for a consultation on minor dermatological conditions, lessen wait times and increase Ontarians’ access to Dermatologists regardless of geographic constraints.

Latest Aithority Insights : NVIDIA Raises the Standard of Low Code DevOps with the NVIDIA AI Enterprise 2.1

“Quick, convenient access to specialists with top-quality continuity of care is a cornerstone of the patient experience in MCI’s high performance healthcare network. This collaboration with Oro Health expands our convenient virtual care offering and accelerates access to specialty care,” said Dr. Alexander Dobranowski, CEO of MCI. “Additionally, this innovative platform creates a unique draw for the recruitment of specialists to our network, so that even more patients can be given the care they need quickly. MCI is firmly committed to our mission to make healthcare more accessible, affordable and ultimately safer and we’re grateful for innovative partners like Oro Health who share this goal.”

The MCI Dermatology Connect platform provides specific solutions needed for virtual dermatology care, including secure transfer of high-resolution imaging between patient and specialist. The innovative platform utilizes Oro Health technology that employs dynamic intelligent triage, facilitating swift categorization and assessment of a patient’s dermatological condition. Integrated tools such as predefined templates for prescriptions, diagnosis and treatment, cultivates a streamlined care environment for both MCI patients and practitioners. Moreover, asynchronous teledermatology eliminates the necessity for set appointments between the patient and physician, widening the possibilities for swift physician response and the delivery of appropriate care, leading to expected improvements in patient experience and health outcomes. The collaboration accelerates MCI’s vision to transform primary care delivery with precision medicine technologies, novel referral optimization and custom tech-forward initiatives.

“We are excited to collaborate with MCI Onehealth and provide our technology to enable a new teledermatology online consultation service for Ontario-based patients awaiting faster and broader access to dermatological care,” said Dr. Emilie Bourgeault, CEO of Oro Health, BSc., M.D., Dermatologist (FRCPC).

MCI is already a leader in the virtual/telehealth care sector with 300,000 annual patient visits via telephone or MCI’s general health virtual platform, MCI Connect. This collaboration with Oro Health demonstrates MCI’s continued commitment to the expansion of technology-enabled care. In the absence of more providers and resources, greater technological innovation, clinical efficiency and data that is used well can flag gaps in care, target patients for services they’re behind on, provide patients with more options, and help reduce health system costs.

Read More About AI News : Role of AI in Helping B2B companies that are Missing Out on Buyer Intent Data

MCI has built a first-of-its-kind model in community healthcare that is right now demonstrating efficiencies and improving patient access in ways that has not been demonstrated before in Canadian healthcare. MCI’s tech and data-enabled high-performance healthcare network helps address urgent health system issues: remedying system backlogs for patient services, providing greater access to care and diagnostics, providing high-quality continuity of care, speeding time to specialist referrals, identifying optimal care pathways, while accelerating research that supports new health treatments and products.

“MCI’s high-performance healthcare network of patient-facing services allows it to build a much richer and deeper patient profile. Our collaboration with Oro Health, a leader in Asynchronous Telemedicine with image-based AI-driven triaging, will lead to future opportunities to enhance that patient profile, make care more personalized and preventative, and expand the scope of data-driven insights,” added Dobranowski.

Currently, MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Such services are targeted at pharmaceutical companies, life science companies, precision medicine companies and top-tier university centres.

Future of AI-driven Customer Relationship:  Microsoft’s Viva Sales and the Future of AI-driven Customer Relationship and Experience Management

[To share your insights with us, please write to sghosh@martechseries.com]